Search - tctmd.com

Displaying 261 - 280 of 2298

Sort: Relevancy | Date

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

Todd Neale

August 30, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

Caitlin E. Cox

August 28, 2024

News Daily News

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Caitlin E. Cox

August 28, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Todd Neale

August 23, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

More Plants, Fewer Animals: Sources of Dietary Fat Linked to Mortality Risk

Caitlin E. Cox

August 14, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

Todd Neale

August 01, 2024

News Opinion Editor's Corner

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Michael O'Riordan

July 31, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2024

Shelley Wood

July 31, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Daily News

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Michael O'Riordan

July 29, 2024

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

Advertisement

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

ACC/AHA Clarify How Social Determinants of Health Impact CVD

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

More Plants, Fewer Animals: Sources of Dietary Fat Linked to Mortality Risk

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 2024 Dispatch for the CV Team

Semaglutide May Ease Tobacco Use, Study Suggests

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

TCTMD’s Top 10 Most Popular Stories for July 2024

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content